23.01.2014 • News

Oxea Lifts Output of Specialty Esters in Amsterdam

Dallas, Texas-based chemical producer Oxea has widened its capacity for specialty esters at Amsterdam, The Netherlands, by 20%.

The company said its investment, designed to specifically benefit producers of medical devices and flooring looking to replace phthalate-based plasticizers, was in the "single-digit million euro range."

"The increasing demand for phthalate-free plasticizers reaffirms the strategic vision of Oxea and the necessity of continuous investments and initiatives that we have embarked upon to address the industry's changing requirements," said

Cristobal Ascencio, global vice president for oxo derivatives at Oxea.

The company, which also has a base at Oberhausen, Germany, produces several phthalate-free plasticizers at the Amsterdam plant, including Oxsoft TOTM (trioctyl trimellitate) and DOTP (dioctyl terephthalate), marketed under the brand name Oxsoft GPO. 

 

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read